Delivery Order SPE2DB20D3505-SPE2DB25FV1F7
- Not listed
- The Defense Logistics Agency awarded a $5,975.64 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $19,505.72 with a firm fixed price structure. This delivery order, which is a child contract under a larger indefinite delivery vehicle, is scheduled for completion by August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $1,619.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,717.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). Performance will be completed at the contractor's...
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 2, 2025, with a contract value of $1,235.98 and completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a ceiling value of $4,883.67. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,801.80. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical, consistent with AmerisourceBergen's...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV1F7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,694.82 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation, reflecting the vendor's proven capability to meet federal pharmaceutical procurement requirements. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Trulicity, a diabetes medication, represents one of many therapeutic categories within AmerisourceBergen's federal contract portfolio, which also includes neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/5/25 |